A detailed history of Northern Trust Corp transactions in Ac Immune Sa stock. As of the latest transaction made, Northern Trust Corp holds 281,953 shares of ACIU stock, worth $933,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares
281,953
Previous 381,354 26.07%
Holding current value
$933,264
Previous $774,000 9.95%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$1.99 - $3.04 $197,807 - $302,179
-99,401 Reduced 26.07%
281,953 $851,000
Q2 2025

Aug 13, 2025

BUY
$1.48 - $2.2 $6,316 - $9,389
4,268 Added 1.13%
381,354 $774,000
Q1 2025

May 13, 2025

SELL
$1.87 - $2.98 $48,517 - $77,316
-25,945 Reduced 6.44%
377,086 $705,000
Q4 2024

Feb 14, 2025

BUY
$2.67 - $3.75 $1.08 Million - $1.51 Million
403,031 New
403,031 $1.09 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $276M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.